Descrizione del progetto
Migliorare la salute del bestiame grazie alla tecnologia acustica
La mastite bovina è una reazione persistente e infiammatoria del tessuto mammario a seguito di traumi fisici o infezioni provocate da microrganismi. È la malattia più comune nei bovini da latte in tutto il mondo. L’uso continuo di antibiotici per curarla indebolisce la salute dei bovini, perché diminuisce la produzione di latte e, in definitiva, debilita le vacche e ne provoca la rimozione dalla mandria. Il progetto APT, finanziato dall’UE, ha elaborato terapie innovative non invasive senza antibiotici basate sulla tecnologia degli impulsi acustici. Il metodo viene utilizzato con successo da oltre 20 anni nella sanità umana per curare le malattie infiammatorie. Il progetto intende ora impiegarlo nello sviluppo di soluzioni ottimali per la mastite bovina.
Obiettivo
"Armenta Ltd, was established to address the most-costly disease affecting dairy farming today: Bovine Mastitis.
Mastitis is the most pressing disease affecting cows, however antibiotics are the only available option worldwide - close to 50% of antibiotics are used in food producing animals. The continued use of antibiotics in the treatment and prevention of infections of dairy cows has a direct effect on fostering Anti-Microbial Resistance (AMR), an urgent matter of particular public interest. The continued use of antibiotics also weakens the cow’s health, decreasing its milk production and eventually, weak cows are removed from the herd, causing high economic losses that can reach €2.4B per year in Europe alone. Armenta was therefore established to address these pressing economic effects, with a revolutionary way of using APT.
Armenta developed innovative non-invasive; antibiotics free therapies based on acoustic pulse technology (APT). APT has been used for over 20 years in human healthcare treating inflammatory diseases. Armenta employs experts in acoustic pulse treatment and engineering, mastitis researchers, ex-dairy farmers and dairy farming operation, bringing their skills and proficiency into developing the optimal solutions for bovine mastitis.
Armenta aims at becoming a leader in 1) fighting the spread of AMR 2) boosting the dairy economy giving €1.4B cash back to the EU farmers each year 3) increasing cow’s welfare and longevity. Moreover, it aims at being considered the #1 alternative to antibiotics, endorsed by leading international organization.
"
Campo scientifico
- medical and health scienceshealth sciencesinflammatory diseases
- agricultural sciencesanimal and dairy sciencedairy
- natural sciencesphysical sciencesacoustics
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-EIC-SMEInst-2018-2020-3
Meccanismo di finanziamento
SME - SME instrumentCoordinatore
4427120 KFAR SAVA
Israele
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.